Key Highlights
- Relu opens a new office in Boston on 1 October 2024.
- CEO Holger Willems relocates to the U.S. to lead the expansion.
- Focus on accelerating AI adoption in orthodontics and implantology.
- Expansion aims to strengthen client and partner engagement.
- Relu’s AI solutions empower dental labs with innovative workflows.
Source: PR Newswire
Notable Quotes
- “Relocating to the United States, the world’s largest dental market, allows us to be closer to our clients and partners, accelerating the adoption of our AI solutions in orthodontics and implantology.” — Holger Willems, CEO at Relu
- “With Relu stepping onto U.S. soil, we’re not just talking about market growth; we’re setting the stage for a revolution in dental care.” — Philip Toh, President at The Smilist at Relu Board Member
SoHC's Take
Relu’s strategic expansion into the U.S. signals their commitment to staying at the forefront of AI-driven dental technologies. By establishing a direct presence in the world’s largest dental market and having their CEO relocate to lead the charge, Relu is poised to deepen its engagement with clients and accelerate the adoption of its innovative solutions in orthodontics and implantology. This move highlights Relu’s ongoing mission to revolutionize dental care with automation, making treatments faster, safer, and more efficient for practitioners worldwide.
Heading
Key Highlights Ginkgo Bioworks releases first proprietary protein LLM, trained on exclusive datasets.Collaboration with Google Cloud enables AI-driven drug discovery tools.Open API allows researchers to access Ginkgo’s machine ...
Key Highlights Courtney Green joins QGenda as Vice President of Nurse and Staff Solutions.Brings over 20 years of clinical and operational leadership experience.Focus on optimizing ...
Key Highlights Vyne Medical® acquires Extract Systems®, a leader in data extraction solutions.Accelerates healthcare automation by integrating AI and machine learning ...
Key Highlights PatientPay integrates with Azalea Health’s API to streamline patient billing for ambulatory providers.Faster revenue capture with less than 14 days to payment, ...
Key Highlights Partnership streamlines revenue cycle management for ABA therapy providers.Flychain’s financial tools offer real-time insights, secure funding, and automation.Raven ...
Key Highlights Nura Bio closes $140M Series A financing to support clinical development.Shilpa Sambashivan, Ph.D., appointed as CEO following Phase 1 success ...
